Peter and Dan discuss takeaways fromAbundance 360, Peter’s executive summit where four rockstar longevity CEOs summarized new capabilities in the healthcare industry. These cutting-edge companies, whose early experiments have produced amazing results, will have therapies and drugs on the market in the next one to five years. In this episode: Peter mentions Mark Allen, the CEO of Elevian, on the “young blood” research he’s commercializing. He also explains the research and early stage...